Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0216P0211
Contract
Obligated and Ceiling
- Obligated (net)
- $53,348.69
- Ceiling (potential value, not spending)
- $164,721.39
- Current value
- $53,348.69
- Gross positive obligations
- $220,855.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GENMARK DIAGNOSTICS INC. · ZKZ6C6X3XLD3
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0216P0211
- Award type code
- B
- Actions
- 6 · Aug 15, 2016 to Jul 12, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 12, 2018 | FY2018 | P00005 | D | $284.00 | — |
| Jun 13, 2018 | FY2018 | P00004 | F | −$167,506.31 | — |
| Oct 18, 2017 | FY2018 | P00003 | C | $109,198.30 | — |
| May 19, 2017 | FY2017 | P00002 | G | $0.00 | — |
| Oct 21, 2016 | FY2017 | P00001 | C | $111,372.70 | — |
| Aug 15, 2016 | FY2016 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.